Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-verapamil for prophylaxis of episodic cluster headache (Phase 2, randomized, placebo-controlled)
2012-003729-62Phase 2Completed
- Sponsor
- Center Laboratories, Inc.
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of verapamil in Cluster Headache (CH) (2 arms), sponsored by Center Laboratories, Inc. Primary endpoint: Change in average daily frequency of attacks. Started Oct 2012; status: completed.
02
Drugs
verapamil
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on 2012-003729-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003729-62.